TL 383 TL 383 (Terazosin 1 mg)

Pill imprint TL 383 TL 383 has been identified as Terazosin hydrochloride 1 mg.

Terazosin is used in the treatment of benign prostatic hyperplasia; high blood pressure; hyperhidrosis and belongs to the drug class antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy. Terazosin 1 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for TL 383 TL 383 (Terazosin 1 mg)

Terazosin hydrochloride 1 mg TL 383 TL 383
Terazosin hydrochloride 1 mg TL 383 TL 383
Terazosin hydrochloride
Imprint:
TL 383
TL 383
Strength:
1 mg
Color:
Gray
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Antiadrenergic agents, peripherally acting
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Cadista
National Drug Code (NDC):
59746-0383
Inactive Ingredients:
ferrosoferric oxide
gelatin
lactose monohydrate
magnesium stearate
sodium lauryl sulfate
titanium dioxide
corn starch
silicon dioxide
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
67544-0581 Prepak Systems Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Hide
(web2)